Fasting Insulin: The Test You Have to Ask For

What It Can Tell You, and What It Can’t

Most people leave their yearly checkup with a handful of numbers and a general sense of relief. Blood pressure, cholesterol, fasting glucose, maybe a hemoglobin A1c. Nothing flagged in red. Come back next year. Yet millions of those same people are already several years into a metabolic process that will eventually be called prediabetes, then type 2 diabetes, then a cardiac event — and not one line on their lab report said so.

The reason is simple, and once you understand it, it is difficult to unsee. The standard panel measures the outcome of your metabolism — how much sugar is floating in your blood — but not the effort your body is expending to produce that outcome. That effort is reflected in fasting insulin, a test that is inexpensive and widely available but is not part of any routine screening panel. Its absence is not an oversight. No major professional society currently recommends fasting insulin for population screening, for reasons worth understanding before you decide whether it belongs in your own workup.

Think of blood glucose as the reading on a thermostat and insulin as the furnace working to hold it there. A normal room temperature tells you nothing about whether the furnace is idling quietly or running flat out at maximum capacity, straining toward failure. Fasting insulin reflects how hard the furnace is working.

The encouraging part of this story is that insulin resistance responds to lifestyle change more reliably than almost any other chronic condition in medicine — and that the behaviors that improve it are worth adopting whether or not you ever have this particular number measured. What follows is meant to help you have a more informed conversation with your physician about whether fasting insulin adds anything useful to your picture, and what a structured, medically supervised intervention can accomplish for people who turn out to be metabolically at risk.

What Fasting Insulin Actually Measures

Insulin is the hormone your pancreas releases to move glucose out of the bloodstream and into muscle, liver, and fat cells. When those cells respond readily to the signal, a small amount of insulin does the job. When they stop listening — the condition known as insulin resistance — the pancreas compensates by shouting louder, secreting progressively more insulin to force the same amount of glucose into increasingly reluctant tissue.

A fasting insulin test, drawn after eight to twelve hours without food, captures the volume of that shout at rest. It is reported in microunits per milliliter (µIU/mL). Crucially, it can be substantially elevated for years while fasting glucose and A1c remain squarely within the normal range, because the pancreas is succeeding at its job. The test does not detect diabetes. It reflects the conditions that produce diabetes, often long before the diagnosis is available.

That distinction matters for anyone who wants to intervene early rather than manage a disease later. As Pritikin’s overview of why “normal” labs can be misleading points out, a research team at the University of North Carolina applying a comprehensive definition of metabolic health to national survey data found that only about 12% of American adults qualified. The other 88% are not all sick. But many of them sit somewhere on a gradient that standard screening does not fully capture.

Why the Pancreas Compensates for Years Before Glucose Rises

The pancreas is a remarkably accommodating organ. Its beta cells can expand output several-fold to hold blood sugar steady against rising resistance, and they will do so quietly, without symptoms, for a very long time. This period of compensatory high insulin — hyperinsulinemia — is understood to be the true beginning of type 2 diabetes, though it carries no diagnostic label and triggers no alarm on a standard panel.

Large cohort research has traced these trajectories backward from the moment of diagnosis. In one long-running British study of civil servants, fasting glucose values began drifting upward more than a decade before people met the criteria for diabetes, with insulin dynamics shifting along the way. By the time glucose finally escapes the normal range, the pancreas has been compensating for years. Findings from the UK Prospective Diabetes Study suggested that roughly half of beta-cell function is already gone at the moment type 2 diabetes is formally diagnosed.

That is the clinical problem hidden inside a “normal” lab report. The pancreas does not fail suddenly. It fails gradually, then visibly. The gradual phase is the window in which preservation of beta-cell function is still very much on the table.

The Silent Decade: What Rising Insulin Does Elsewhere in the Body

Focusing only on blood sugar also understates what chronically elevated insulin is doing throughout the body. Insulin is a storage and growth hormone, not merely a glucose regulator, and sustained excess has consequences well beyond the pancreas:

• It suppresses fat breakdown, making stored body fat metabolically difficult to mobilize even during calorie restriction — one reason weight loss feels disproportionately hard for insulin-resistant people.
• It drives hepatic fat production, contributing to elevated triglycerides, lower HDL cholesterol, and non-alcoholic fatty liver disease.
• It promotes sodium retention in the kidney and influences vascular tone, linking hyperinsulinemia to hypertension.
• It contributes to the hormonal disruption seen in polycystic ovary syndrome.
• It is associated with the small, dense LDL particles most strongly implicated in atherosclerosis.

This is why insulin resistance sits at the center of metabolic syndrome, the cluster of abdominal obesity, high triglycerides, low HDL, elevated blood pressure, and elevated fasting glucose that dramatically raises cardiovascular risk. People frequently die of the complications of insulin resistance before they ever receive a diabetes diagnosis.

How a Fasting Insulin Result Is — and Isn’t — Interpreted

This is where fasting insulin becomes genuinely difficult, and where the reasons for its absence from routine panels come into focus.

There is no validated diagnostic cutoff for fasting insulin. Unlike fasting glucose or A1c, which have thresholds established by large outcome studies and endorsed by professional societies, fasting insulin has no number above which a person is formally considered insulin resistant. The commonly cited targets circulating online are expert opinion and convention, not guideline-endorsed criteria.

Insulin assays are also not standardized across laboratories. Different platforms use different antibodies and calibrators, and the same blood sample can produce meaningfully different values at different labs. This is a well-recognized limitation in the field, and it is a substantial part of why fasting insulin has not been adopted for screening. A result from one lab cannot be reliably compared to a result from another.

For those reasons, an isolated fasting insulin value tells you very little on its own. What carries more information is the direction of travel over time — repeat measurements at the same laboratory, interpreted alongside fasting glucose and the rest of your metabolic picture. A single elevated reading is a prompt for a conversation, not a diagnosis, and it should always be interpreted with your physician rather than against a threshold found on the internet.

A few further practical points to raise with your doctor:

• Laboratory reference ranges for fasting insulin are wide — frequently extending to roughly 25 µIU/mL — because they describe the distribution of results in a broadly unhealthy population, not a validated target. “In range” and “optimal” are not the same thing, but neither is there an agreed-upon optimum.
• Pairing the test with fasting glucose allows calculation of HOMA-IR: fasting insulin (µIU/mL) multiplied by fasting glucose (mg/dL), divided by 405. HOMA-IR was developed primarily as a research and population-level tool; published thresholds vary considerably between populations, and it inherits the same assay-standardization problem as the insulin value it is built from.
• Acute illness, poor sleep, unusual stress, or a hard workout the day before can shift results. No conclusion should be drawn from a single surprising value.
• For anyone already taking injected insulin, the test cannot distinguish injected from endogenous insulin; a C-peptide test is the relevant measure of the pancreas’s own remaining output.

Whether This Test Belongs in Your Workup

Fasting insulin is not part of standard panels and is not recommended for routine screening, so for many people the honest answer is that it will not change what they should do next. If your glucose, A1c, lipids, blood pressure, and waist measurement are all reassuring, adding an insulin value with no validated cutoff is unlikely to add much. And if those markers already point toward metabolic risk, the recommended interventions are largely the same regardless of what your insulin number turns out to be.

Where the test can add something is in a specific conversation with a physician who knows your history — someone with a strong family history of type 2 diabetes, a prior gestational diabetes diagnosis, PCOS, fatty liver, central adiposity, or a triglyceride-to-HDL ratio that looks off despite normal glucose. In those situations, some clinicians find fasting insulin and HOMA-IR useful as one input among several, particularly when tracked over time. Others reasonably prefer to rely on markers with validated thresholds and guideline support. Both are defensible positions, and your physician is better placed than an article to judge which applies to you.

If you want to open that discussion, a useful framing is: “My glucose looks fine, but I have [family history / these lipid findings / this waist measurement] — is there anything further worth measuring, and would fasting insulin add anything for someone in my situation?” That reframes the visit from disease detection to risk prevention without presuming the answer.

The markers below are the ones most often discussed in that conversation. Some are routine, some are not, and which of them make sense depends on your individual risk profile — this is a starting point for a discussion, not a list to hand across the desk:

• Hemoglobin A1c and fasting glucose
• A full lipid panel, with attention to the triglyceride-to-HDL ratio
• ApoB, for a direct count of atherogenic particles
• hs-CRP, as a marker of low-grade inflammation
• Liver enzymes, particularly ALT, which often signals fatty liver
• Your waist measurement divided by your height, which you can take yourself and which requires no lab at all

What Actually Improves Insulin Sensitivity

The most important thing about insulin resistance is how responsive it is. Insulin sensitivity improves quickly — often within days — when the inputs driving it change. The levers are well established, and none of them require a lab result to justify:

Food quality over carbohydrate avoidance. Unrefined, high-fiber, water-rich carbohydrates behave very differently in the body than refined flour and sugar, which is why Pritikin’s guidance on reversing diabetes with the right carbohydrates runs counter to popular low-carb assumptions while remaining consistent with the clinical evidence.

Meal composition and order. Eating vegetables, fiber, and protein before starch measurably blunts the post-meal glucose and insulin response, a technique explored in Pritikin’s work on food sequencing for blood sugar control.

Daily movement, especially after meals. Muscle takes up glucose during activity through pathways that do not depend on insulin, which is why even a modest post-meal walk has an outsized effect on lowering blood glucose.

Resistance training. Muscle is the body’s largest glucose disposal site, and preserving it protects insulin sensitivity as you age.

Reducing red and processed meat. Researchers at the Harvard School of Public Health have linked higher intake, particularly of processed meat, to substantially elevated type 2 diabetes risk.

Sleep and stress management. Even a few nights of short sleep meaningfully impair insulin sensitivity in healthy adults, and chronically elevated cortisol works directly against the pancreas.

None of this is exotic. The difficulty has never been knowing what to do. It is doing it consistently, inside a life and a food environment engineered against you.

The Pritikin Evidence

This is where a structured, immersive intervention earns its place. The Pritikin Program has been studied continuously for nearly five decades, with results documented in more than 100 peer-reviewed medical journals — a depth of validation no other resort-based program can claim.

The insulin-specific findings are notable. Research cited in Pritikin’s clinical overview of controlling and reversing diabetes has found that the program reduces fasting insulin by 25 to 40%. In a study of 243 people in the early stages of diabetes who were not yet taking medication, average fasting glucose fell from 160 to 124 within three weeks. In separate research, half of the adults studied no longer met the clinical criteria for metabolic syndrome after three weeks on the program.

For broader context on prevention, the NIH-sponsored Diabetes Prevention Program followed more than 3,000 prediabetic adults and found that lifestyle change reduced progression to type 2 diabetes by 58% — and by 71% among adults aged 60 and older — compared with 31% for metformin. Lifestyle outperformed the drug, substantially. Pritikin’s discussion of how long it takes to reverse diabetes puts realistic timelines around that finding.

What an Immersive Reset Looks Like in Doral

At the Pritikin Longevity Center in Doral, Florida, guests work with a physician-led team of doctors, registered dietitians, exercise physiologists, and behavioral specialists. Comprehensive labs are drawn on site, and the results are interpreted by that medical team as part of a personalized plan — rather than a number you take home and puzzle over alone.

The daily structure is built to make the science tangible. The Pritikin Eating Plan is not described in a handout — it is served at every meal, so guests learn what satiating, blood-sugar-stabilizing food actually tastes and feels like. The cooking school converts that experience into skills that survive the trip home. The exercise program rebuilds capacity at whatever fitness level a guest arrives with, and the healthy mindset sessions address the behavioral patterns that determine whether change lasts past week three. For guests whose primary concern is blood sugar, the diabetes retreat concentrates that expertise around glucose and insulin management, with medications adjusted under medical supervision as numbers improve. The documented results — in weight, blood pressure, lipids, glucose, and fitness — are measured, published, and repeatable.

Starting the Conversation

Talk with your physician about where you actually sit on the metabolic risk gradient, and let that conversation determine which measurements are worth adding. Fasting insulin may be part of that discussion or it may not; what matters more is that the question gets asked at all, and that the answer is interpreted by someone who knows your history rather than read off a chart. The gradient this article describes is real, it is common, and it responds well to intervention — and the earlier in that gradient you find yourself, the more effective the response tends to be.

To speak with a Pritikin representative about your health picture, your goals, and whether an immersive stay makes sense for your situation, visit pritikin.com/book or call (800) 327-4914. A short conversation can clarify how the program works for someone with your specific health picture — and how quickly a pancreas that has been compensating for years can finally get some relief.